IGM BIOSCIENCES INC. - COMMON STOCK

IGM Biosciences Announces Refocusing of Sanofi Collaboration

17 Apr 2024 07:30:58 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum

10 Apr 2024 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

07 Mar 2024 15:10:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

01 Feb 2024 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 Jan 2024 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension

05 Dec 2023 15:01:00 By Nasdaq GlobeNewswire

IGM Biosciences Announces Third Quarter 2023 Financial Results

13 Nov 2023 15:10:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at Two Upcoming Investor Conferences

07 Nov 2023 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of Directors

03 Oct 2023 15:05:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

06 Sep 2023 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences Announces Second Quarter 2023 Financial Results

03 Aug 2023 15:10:00 By Nasdaq GlobeNewswire

IGM Announces Closing of Upsized Public Offering and Concurrent Private Placement and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

03 Jul 2023 15:01:00 By Nasdaq GlobeNewswire

IGM Announces Pricing of $107.3 Million Upsized Public Offering and Concurrent Private Placement

22 Jun 2023 06:58:50 By Nasdaq GlobeNewswire

IGM Announces Proposed Public Offering and Concurrent Private Placement

21 Jun 2023 16:17:00 By Nasdaq GlobeNewswire

IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development

02 Jun 2023 16:30:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at the Jefferies Healthcare Conference

01 Jun 2023 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences Announces FDA Clearance to Begin Clinical Studies of Imvotamab in Lupus and Rheumatoid Arthritis

31 May 2023 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences to Host Conference Call and Webcast to Provide IGM-8444 Clinical Update

30 May 2023 06:00:00 By Nasdaq GlobeNewswire

IGM Biosciences Announces First Quarter 2023 Financial Results and Provides Corporate Update

12 May 2023 08:05:00 By Nasdaq GlobeNewswire

IGM Biosciences to Present at Two Upcoming Investor Conferences

02 May 2023 06:00:01 By Nasdaq GlobeNewswire